Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection
Clinical trial NCT01768286 · COMPLETED
Trial details
- NCT number
- NCT01768286
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-11-01
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.